Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.31B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$339M |
| 3 |
Tesla
TSLA
|
+$275M |
| 4 |
Alibaba
BABA
|
+$236M |
| 5 |
AGN
Allergan plc
AGN
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
| 2 |
Gilead Sciences
GILD
|
+$359M |
| 3 |
Amazon
AMZN
|
+$274M |
| 4 |
Intel
INTC
|
+$248M |
| 5 |
Microsoft
MSFT
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.94% |
| 2 | Technology | 2.38% |
| 3 | Consumer Discretionary | 1.42% |
| 4 | Communication Services | 1.04% |
| 5 | Healthcare | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3076
CALL
WEC Energy
WEC
$34.7B
| $3.27M | ﹤0.01% |
52,000
+5,700
| +12% | +$364K |
|
3077
CALL
Amdocs
DOX
$6.6B
| $3.26M | ﹤0.01% |
50,700
+4,100
| +9% | +$265K |
|
3078
Federated Hermes
FHI
$4.88B
| $3.26M | ﹤0.01% |
109,700
-15,114
| -12% | -$425K |
|
|
CBL
3079
CALL
DELISTED
CBL& Associates Properties, Inc.
CBL
| $3.26M | ﹤0.01% |
388,100
+92,700
| +31% | +$786K |
|
3080
Invesco Dorsey Wright Financial Momentum ETF
PFI
$59.8M
| $3.25M | ﹤0.01% |
98,729
+67,057
| +212% | +$2.14M |
|
3081
VanEck Retail ETF
RTH
$253M
| $3.25M | ﹤0.01% |
39,916
+17,639
| +79% | +$1.42M |
|
3082
CALL
MasTec
MTZ
$19.5B
| $3.25M | ﹤0.01% |
70,100
-22,500
| -24% | -$980K |
|
3083
CALL
B&G Foods
BGS
$284M
| $3.25M | ﹤0.01% |
102,000
-122,600
| -55% | -$4.03M |
|
3084
Energous
WATT
$62.5M
| $3.25M | ﹤0.01% |
427
+34
| +9% | +$266K |
|
3085
Dine Brands
DIN
$422M
| $3.24M | ﹤0.01% |
75,435
+53,019
| +237% | +$2.17M |
|
|
SEE
3086
PUT
DELISTED
Sealed Air
SEE
| $3.24M | ﹤0.01% |
75,800
-80,200
| -51% | -$3.55M |
|
3087
CALL
Core Laboratories
CLB
$564M
| $3.24M | ﹤0.01% |
32,800
-10,700
| -25% | -$1.04M |
|
3088
W.P. Carey
WPC
$16.1B
| $3.24M | ﹤0.01% |
49,027
+22,481
| +85% | +$1.5M |
|
|
GBT
3089
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $3.23M | ﹤0.01% |
104,000
-9,500
| -8% | -$267K |
|
3090
PUT
NovoCure
NVCR
$2.07B
| $3.23M | ﹤0.01% |
162,600
+79,900
| +97% | +$1.57M |
|
3091
Whirlpool
WHR
$2.65B
| $3.23M | ﹤0.01% |
17,500
| – | – |
|
3092
CubeSmart
CUBE
$9.03B
| $3.23M | ﹤0.01% |
124,320
+24,179
| +24% | +$598K |
|
|
KYNB
3093
Kyntra Bio
KYNB
$32.2M
| $3.23M | ﹤0.01% |
2,399
-527
| -18% | -$555K |
|
|
CHUBK
3094
DELISTED
CommerceHub, Inc. Series C Common Stock
CHUBK
| $3.23M | ﹤0.01% |
+151,041
| New | +$2.97M |
|
3095
CALL
ITT
ITT
$18.1B
| $3.22M | ﹤0.01% |
72,800
-3,400
| -4% | -$140K |
|
3096
CALL
Direxion Daily FTSE China Bull 3X ETF
YINN
$668M
| $3.22M | ﹤0.01% |
5,535
+875
| +19% | +$476K |
|
|
RUSL
3097
DELISTED
Direxion Daily Russia Bull 2X Shares
RUSL
| $3.22M | ﹤0.01% |
61,383
+49,427
| +413% | +$2.09M |
|
3098
PUT
Calumet Specialty Products
CLMT
$4.2B
| $3.22M | ﹤0.01% |
385,300
+155,300
| +68% | +$968K |
|
|
CRC
3099
PUT
DELISTED
California Resources Corporation
CRC
| $3.22M | ﹤0.01% |
307,600
-179,100
| -37% | -$1.43M |
|
|
JBTM
3100
CALL
JBT Marel
JBTM
$6.08B
| $3.21M | ﹤0.01% |
31,800
-17,300
| -35% | -$1.6M |
|
Similar funds
Jeff Yass's Q3 2017 Portfolio in Review
As of Q3 2017, Jeff Yass held 10,422 positions worth $259B, up 14% from $228B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2017 filing shows 1,312 new, 3,605 increased, 3,645 reduced and 1,693 closed positions. Its largest new stake was JPMorgan Chase: 794,224 shares worth $75.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $474M.
By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2017 buy was JPMorgan Chase: 794,224 shares worth $75.9M.
- Jeff Yass added most to Apple in Q3 2017, an estimated $1.31B increase.
- Jeff Yass's biggest Q3 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $474M.
- Jeff Yass fully exited iShares 20+ Year Treasury Bond ETF in Q3 2017, selling an estimated $69.3M.
- Jeff Yass's ten largest holdings make up 24% of its $259B portfolio in Q3 2017.
- Jeff Yass opened 1,312 new positions and closed 1,693 in Q3 2017.
- Jeff Yass's portfolio value rose 14% quarter-over-quarter to $259B.
Based on Susquehanna International Group's 13F filing for Q3 2017, filed 14 Nov 2017.